Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,234,104
+$81,092 QoQ
Shares Held
3,408
+4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,552
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN STREET ADVISORS INC /NC holds $55,471,815 across 7 Drug Manufacturers - General names. AMGN ranks #3 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
181,638 | $45,707,386 | |
| 2 | JNJ |
Johnson & Johnson
|
19,450 | $4,939,716 | |
| 3 | AMGN |
Amgen Inc
This page
|
3,408 | $1,234,104 | |
| 4 | LLY |
ELI LILLY & Co
|
1,009 | $1,210,224 | |
| 5 | PFE |
Pfizer Inc
|
46,667 | $1,123,741 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,476 | $944,517 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,417 | $312,127 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,234,104 | 3,408 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $1,153,012 | 3,277 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $1,074,231 | 3,282 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $895,138 | 3,172 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $943,171 | 3,378 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $7,608,674 | 24,422 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $12,092,653 | 46,396 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $18,739,089 | 58,158 | Shares | Defined | 2024-10-09 | |
| 2024-06-30 | $17,941,816 | 57,423 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $14,759,051 | 51,910 | Shares | Defined | 2024-04-15 | |
| 2023-12-31 | $13,561,133 | 47,084 | Shares | Defined | 2024-01-18 | |
| 2023-09-30 | $11,552,111 | 42,983 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $8,776,006 | 39,528 | Shares | Defined | 2023-07-13 | |
| 2023-03-31 | $9,219,378 | 38,136 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $10,101,397 | 38,461 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $8,923,360 | 39,589 | Shares | Defined | 2022-10-11 | |
| 2022-06-30 | $8,616,469 | 35,415 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $4,405,718 | 18,219 | Shares | Defined | 2022-04-18 | |
| 2021-12-31 | $1,209,213 | 5,375 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $565,861 | 2,661 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $645,937 | 2,650 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $671,787 | 2,700 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $664,928 | 2,892 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $741,893 | 2,919 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $634,935 | 2,692 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $644,275 | 3,178 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||